» Articles » PMID: 11438726

Mechanistic Coupling of Protease Signaling and Initiation of Coagulation by Tissue Factor

Overview
Specialty Science
Date 2001 Jul 5
PMID 11438726
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

The crucial role of cell signaling in hemostasis is clearly established by the action of the downstream coagulation protease thrombin that cleaves platelet-expressed G-protein-coupled protease activated receptors (PARs). Certain PARs are cleaved by the upstream coagulation proteases factor Xa (Xa) and the tissue factor (TF)--factor VIIa (VIIa) complex, but these enzymes are required at high nonphysiological concentrations and show limited recognition specificity for the scissile bond of target PARs. However, defining a physiological mechanism of PAR activation by upstream proteases is highly relevant because of the potent anti-inflammatory in vivo effects of inhibitors of the TF initiation complex. Activation of substrate factor X (X) by the TF--VIIa complex is here shown to produce enhanced cell signaling in comparison to the TF--VIIa complex alone, free Xa, or Xa that is generated in situ by the intrinsic activation complex. Macromolecular assembly of X into a ternary complex of TF--VIIa--X is required for proteolytic conversion to Xa, and product Xa remains transiently associated in a TF--VIIa--Xa complex. By trapping this complex with a unique inhibitor that preserves Xa activity, we directly show that Xa in this ternary complex efficiently activates PAR-1 and -2. These experiments support the concept that proinflammatory upstream coagulation protease signaling is mechanistically coupled and thus an integrated part of the TF--VIIa-initiated coagulation pathway, rather than a late event during excessive activation of coagulation and systemic generation of proteolytic activity.

Citing Articles

Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.

Muller-Calleja N, Grunz K, Nguyen T, Posma J, Pedrosa D, Meineck M Blood. 2023; 143(12):1167-1180.

PMID: 38142429 PMC: 10972716. DOI: 10.1182/blood.2023022276.


Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells.

Ruf L, Bukowska A, Gardemann A, Goette A Cells. 2023; 12(24).

PMID: 38132169 PMC: 10741780. DOI: 10.3390/cells12242849.


Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.

Girard T, Antunes L, Zhang N, Amrute J, Subramanian R, Eldem I J Thromb Haemost. 2023; 21(3):629-638.

PMID: 36696180 PMC: 9773443. DOI: 10.1016/j.jtha.2022.11.033.


Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH.

Wilkinson H, Leonard H, Robson M, Smith R, Tam E, McVey J Front Immunol. 2022; 13:999871.

PMID: 36172348 PMC: 9510775. DOI: 10.3389/fimmu.2022.999871.


Cancer-related stroke: Exploring personalized therapy strategies.

Chen Y, Dong R, Zhang M, Sheng C, Guo P, Sun J Brain Behav. 2022; 12(9):e2738.

PMID: 35938982 PMC: 9480895. DOI: 10.1002/brb3.2738.


References
1.
Sevinsky J, Rao L, Ruf W . Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996; 133(2):293-304. PMC: 2120798. DOI: 10.1083/jcb.133.2.293. View

2.
Baugh R, Dickinson C, Ruf W, Krishnaswamy S . Exosite interactions determine the affinity of factor X for the extrinsic Xase complex. J Biol Chem. 2000; 275(37):28826-33. DOI: 10.1074/jbc.M005266200. View

3.
Higuchi D, Wun T, Likert K, Broze Jr G . The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood. 1992; 79(7):1712-9. View

4.
Camerer E, Rottingen J, Iversen J, Prydz H . Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem. 1996; 271(46):29034-42. DOI: 10.1074/jbc.271.46.29034. View

5.
Mueller B, Ruf W . Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest. 1998; 101(7):1372-8. PMC: 508714. DOI: 10.1172/JCI930. View